Unknown

Dataset Information

0

The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers.


ABSTRACT: Various forms of oncogenic ALK proteins have been identified in various types of human cancers. While Crizotinib, an ALK inhibitor, has been found to be therapeutically useful against a subset of ALK(+) tumours, clinical resistance to this drug has been well recognized and the mechanism of this phenomenon is incompletely understood. Using the cellular thermal shift assay (CETSA), we measured the Crizotinib-ALK binding in a panel of ALK(+) cell lines, and correlated the findings with the ALK structure and its interactions with specific binding proteins. The Crizotinib IC50 significantly correlated with Crizotinib-ALK binding. The suboptimal Crizotinib-ALK binding in Crizotinib-resistant cells is not due to the cell-specific environment, since transfection of NPM-ALK into these cells revealed substantial Crizotinib-NPM-ALK binding. Interestingly, we found that the resistant cells expressed higher protein level of ?-catenin and siRNA knockdown restored Crizotinib-ALK binding (correlated with a significant lowering of IC50). Computational analysis of the crystal structures suggests that ?-catenin exerts steric hindrance to the Crizotinib-ALK binding. In conclusion, the Crizotinib-ALK binding measurable by CETSA is useful in predicting Crizotinib sensitivity, and Crizotinib-ALK binding is in turn dictated by the structure of ALK and some of its binding partners.

SUBMITTER: Alshareef A 

PROVIDER: S-EPMC5027386 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2017-01-01 | S-EPMC5555621 | BioStudies
2015-01-01 | S-EPMC4588301 | BioStudies
2015-01-01 | S-EPMC4529334 | BioStudies
1000-01-01 | S-EPMC5715105 | BioStudies
2019-01-01 | S-EPMC6684801 | BioStudies
1000-01-01 | S-EPMC5912135 | BioStudies
2017-01-01 | S-EPMC5617123 | BioStudies
2014-01-01 | S-EPMC4170597 | BioStudies
2016-01-01 | S-EPMC4773904 | BioStudies
2015-01-01 | S-EPMC4395299 | BioStudies